{"id":4123,"date":"2026-01-21T22:40:38","date_gmt":"2026-01-21T22:40:38","guid":{"rendered":"https:\/\/benzifoundation.org\/expertise\/etica-e-regolatorio\/"},"modified":"2026-03-24T16:06:50","modified_gmt":"2026-03-24T16:06:50","slug":"etica-e-regolatorio","status":"publish","type":"page","link":"https:\/\/benzifoundation.org\/it\/expertise\/etica-e-regolatorio\/","title":{"rendered":"Etica e regolatorio"},"content":{"rendered":"<div class=\"et_pb_section_0 et_pb_section et_section_regular et_block_section et_pb_section_parallax headerAll\"><span class=\"et-pb-parallax-wrapper\"><span class=\"et-pb-parallax-background et-pb-parallax-background-module--divi-section-0\" style=\"background-image:url(https:\/\/benzifoundation.org\/wp-content\/uploads\/2026\/01\/exP_ethics_header.jpg)\"><\/span><\/span>\n<div class=\"et_pb_row_0 et_pb_row et_block_row\">\n<div class=\"et_pb_column_0 et_pb_column et_pb_column_4_4 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_text_0 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module\"><div class=\"et_pb_text_inner\"><h2><span id=\"result_box\" class=\"short_text\" lang=\"en\">Expertise<\/span><\/h2>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n<div class=\"et_pb_section_1 et_pb_section et_section_regular et_block_section\">\n<div class=\"et_pb_row_1 et_pb_row et_block_row et_animated\">\n<div class=\"et_pb_column_1 et_pb_column et_pb_column_4_4 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_text_1 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module titViola1\"><div class=\"et_pb_text_inner\"><h2>ETICA E REGOLATORIO<\/h2>\n<\/div><\/div>\n\n<div class=\"et_pb_divider_0 et_pb_divider et_pb_space et_pb_divider_position_top et_pb_module divid1\"><div class=\"et_pb_divider_internal\"><\/div><\/div>\n\n<div class=\"et_pb_text_2 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module strongViola\"><div class=\"et_pb_text_inner\"><p class=\"cvGsUA direction-ltr align-center para-style-body\">Promuovere la conformit\u00e0 agli standard europei in materia di <span class=\"a_GcMg font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\" style=\"color:#871952;font-weight:bold;\"><span class=\"a_GcMg font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">procedure etiche e regolatorie<\/span><\/span> \u00e8 una delle nostre principali attivit\u00e0..<\/p>\n<p class=\"cvGsUA direction-ltr align-center para-style-body\">In questo ambito, contribuiamo a numerosi <span class=\"a_GcMg font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"><a href=\"https:\/\/benzifoundation.org\/it\/progetti\/\"><span class=\"a_GcMg font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\" style=\"color:#871952;font-weight:bold;\"><span class=\"a_GcMg font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">progetti collaborativi di ricerca internazionale<\/span><\/span><\/a><\/span> che richiedono supporto regolatorio ed etico. Siamo attivamente coinvolti nella preparazione dei Piani di Indagine Pediatrica (Paediatric Investigational Plans), nelle procedure di Designazione Orfana, nella redazione di documenti guida e modelli per il consenso informato e l\u2019assenso pediatrico, nonch\u00e9 negli accordi di trasferimento di materiali e dati.<\/p>\n<p><\/p>\n<p class=\"cvGsUA direction-ltr align-center para-style-body\"><span class=\"a_GcMg font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Inoltre, i nostri rappresentanti, in qualit\u00e0 di esperti nel campo regolatorio, sono o sono stati membri del Comitato Pediatrico presso l\u2019Agenzia Europea per i Medicinali (EMA) e di altri rilevanti comitati scientifici e gruppi di lavoro presso l\u2019Agenzia Italiana del Farmaco (AIFA), l\u2019Agenzia Nazionale per i Servizi Sanitari Regionali (AGENAS) e l\u2019Agenzia Regionale per la Salute e il Sociale della Puglia.<\/span><\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n<div class=\"et_pb_section_2 et_pb_section et_section_regular et_block_section\">\n<div class=\"et_pb_row_2 et_pb_row et_block_row et_animated\">\n<div class=\"et_pb_column_2 et_pb_column et_pb_column_4_4 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_text_3 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module titViola1\"><div class=\"et_pb_text_inner\"><h2>Consultazioni pubbliche<\/h2>\n<\/div><\/div>\n\n<div class=\"et_pb_divider_1 et_pb_divider et_pb_space et_pb_divider_position_top et_pb_module divid1\"><div class=\"et_pb_divider_internal\"><\/div><\/div>\n\n<div class=\"et_pb_text_4 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module strongViola\"><div class=\"et_pb_text_inner\"><p>La consolidata esperienza rende la Fondazione Gianni Benzi una voce autorevole a livello europeo nell\u2019<strong>ambito etico e regolatorio<\/strong>. Tale competenza si traduce nell\u2019elaborazione di documenti e nella partecipazione concreta alle <strong>consultazioni pubbliche<\/strong> avviate dalle autorit\u00e0 competenti su diversi temi di nostro interesse: etica, politiche per le malattie rare e pediatriche, sperimentazioni cliniche, studi preclinici, privacy e riservatezza, e valorizzazione del ruolo dei pazienti nello sviluppo dei farmaci. <\/p>\n<p><span style=\"font-size: 18px; color: #8b2055;\"><\/span><\/p>\n<p><span style=\"font-size: 18px; color: #8b2055;\">Questa \u00e8 la lista delle consultazioni pubbliche a cui Fondazione Gianni Benzi ha participato direttamente:<\/span><\/p>\n<\/div><\/div>\n\n<div class=\"et_pb_text_5 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module linkList\"><div class=\"et_pb_text_inner\"><div data-tid=\"messageBodyContainer\">\n<div data-tid=\"messageBodyContent\">\n<ul>\n<li><a href=\"https:\/\/www.ema.europa.eu\/en\/documents\/presentation\/presentation-outcomes-ema-survey-orphan-maintenance-assessment-reports-omars-kristina-larsson_en.pdf\" target=\"_blank\" rel=\"noopener\"><span class=\"ui-provider hc b c d e f g h i j k l m n o p q r s t u v w x y z ab ac ae af ag ah ai aj ak\" dir=\"ltr\">EMA Survey on Orphan Maintenance Assessment Reports (OMARs) - (November, 2021)<\/span><\/a><\/li>\n<li><a href=\"https:\/\/www.aifa.gov.it\/en\/-\/aifa-avvia-la-consultazione-pubblica-sulle-linee-guida-per-la-domanda-di-rimborsabilita-e-prezzo-di-un-medicinale\" target=\"_blank\" rel=\"noopener noreferrer\">Linee guida AIFA per la compilazione del Dossier a supporto della domanda di rimborsabilit\u00e0 e prezzo di un medicinale (September, 2020)<\/a><\/li>\n<li><a href=\"https:\/\/ec.europa.eu\/info\/law\/better-regulation\/have-your-say\/initiatives\/12421-Pharmaceutical-Strategy-Timely-patient-access-to-affordable-medicines\/public-consultation\" target=\"_blank\" rel=\"noopener noreferrer\">Survey on the Pharmaceutical Strategy - Timely patient access to affordable medicines (September 2020) <\/a><\/li>\n<li><a href=\"https:\/\/www.benzifoundation.org\/wp-content\/uploads\/2020\/07\/FGB-comments-to-the-EMA-discussion-paper.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Comments to the EMA Discussion Paper \u201cThe General Data Protection Regulation: Secondary Use of Data for Medicines and Public Health Purposes\u201d (July, 2020)<\/a><\/li>\n<li><a href=\"https:\/\/ec.europa.eu\/info\/news\/results-horizon-europe-implementation-co-design-exercise-towards-sound-implementation-framework-2019-nov-26_en\" target=\"_blank\" rel=\"noopener noreferrer\">Horizon Europe Co-design 2021 - 2024 (September, 2019)<\/a><\/li>\n<li>Discussion paper: use of patient disease registries for regulatory purposes - methodological and operational considerations (June, 2019)<\/li>\n<li><a href=\"https:\/\/www.ema.europa.eu\/en\/about-us\/how-we-work\/regulatory-science-2025\" target=\"_blank\" rel=\"noopener noreferrer\">Public Consultation on EMA Regulatory Science to 2025 (June, 2019)<\/a><\/li>\n<li>HMA - EMA Consultation: Role of big data for evaluation and supervision of medicines in the EU (April, 2019)<\/li>\n<li><a href=\"https:\/\/ec.europa.eu\/info\/law\/better-regulation\/have-your-say\/initiatives\/1248-Evaluation-of-the-legislation-on-medicines-for-children-and-rare-diseases-medicines-for-special-populations-\/public-consultation\" target=\"_blank\" rel=\"noopener noreferrer\">Open public consultation for the evaluation of the EU legislation on medicines for rare diseases and children (January, 2019)<\/a><\/li>\n<li><span style=\"color: transparent; cursor: text; font-family: sans-serif; font-size: 13.45px; font-style: normal; font-variant: normal; font-weight: 400; left: 166.08px; letter-spacing: normal; orphans: 2; position: absolute; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; top: 102.75px; transform: scaleX(0.943867); transform-origin: 0px 0px 0px; -webkit-text-stroke-width: 0px; white-space: pre; word-spacing: 0px; padding: 0px;\">Role of big data for evaluation and supervision of <\/span><span style=\"color: transparent; cursor: text; font-family: sans-serif; font-size: 13.45px; font-style: normal; font-variant: normal; font-weight: 400; left: 157.07px; letter-spacing: normal; orphans: 2; position: absolute; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; top: 121.68px; transform: scaleX(0.927745); transform-origin: 0px 0px 0px; -webkit-text-stroke-width: 0px; white-space: pre; word-spacing: 0px; padding: 0px;\">medicines in the <\/span><span style=\"color: transparent; cursor: text; font-family: sans-serif; font-size: 13.45px; font-style: normal; font-variant: normal; font-weight: 400; left: 250.8px; letter-spacing: normal; orphans: 2; position: absolute; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; top: 121.68px; transform: scaleX(0.833135); transform-origin: 0px 0px 0px; -webkit-text-stroke-width: 0px; white-space: pre; word-spacing: 0px; padding: 0px;\">EU<\/span><span style=\"color: transparent; cursor: text; font-family: sans-serif; font-size: 13.45px; font-style: normal; font-variant: normal; font-weight: 400; left: 266.29px; letter-spacing: normal; orphans: 2; position: absolute; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; top: 121.68px; transform: scaleX(1.08588); transform-origin: 0px 0px 0px; -webkit-text-stroke-width: 0px; white-space: pre; word-spacing: 0px; padding: 0px;\"><br \/><\/span><a href=\"https:\/\/ec.europa.eu\/newsroom\/article29\/item-detail.cfm?item_id=623051\" target=\"_blank\" rel=\"noopener noreferrer\">Comments to 17\/EN WP259 Guidelines on Consent under Regulation 2016\/679 (2018)<\/a><\/li>\n<li><a href=\"https:\/\/ec.europa.eu\/info\/law\/better-regulation\/initiatives\/ares-2017-6059807_en\" target=\"_blank\" rel=\"noopener noreferrer\">Orphan Paediatric roadmap (2018)<\/a><\/li>\n<li><a href=\"https:\/\/ec.europa.eu\/health\/medicinal-products-for-human-use\/public-consultation-on-the-revision-of-ethical-considerations-for_ga\" target=\"_blank\" rel=\"noopener noreferrer\">Public Consultation on the revision of Ethical Considerations for Clinical Trials on Medicinal products Conducted with Minors, August 2016<\/a><\/li>\n<li><a href=\"https:\/\/www.ema.europa.eu\/en\/gaucher-disease-strategic-collaborative-approach-european-medicines-agency-food-drug-administration\" target=\"_blank\" rel=\"noopener noreferrer\">EMA\/44410\/2014 Gaucher disease - A strategic collaborative approach from EMA and FDA, August 2014<\/a><\/li>\n<li>Revision of the Clinical Trials Directive 2001\/20\/EC concept paper submitted for public consultation, June 2013<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div><\/div>\n\n<div class=\"et_pb_text_6 et_pb_text et_pb_bg_layout_light et_pb_module et_block_module linkList\"><div class=\"et_pb_text_inner\"><p style=\"text-align: center;\"><span style=\"font-size: 18px; color: #8b2055;\">La Fondazione ha contribuito anche ad altre importanti consultazioni pubbliche, come:<\/span><\/p>\n<ul>\n<li>\n<div data-tid=\"messageBodyContainer\">\n<div data-tid=\"messageBodyContent\">\n<div>\n<div>\n<div><a href=\"https:\/\/ec.europa.eu\/info\/law\/better-regulation\/have-your-say\/initiatives\/12767-Revision-of-the-EU-legislation-on-medicines-for-children-and-rare-diseases\" target=\"_blank\" rel=\"noopener\">Public consultation on the revision of the European legislation on medicines for children and rare diseases (EC - Inception Impact Assessment - Ref. Ares (2020)7081640 - 25\/11\/2020) - (2021)<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/li>\n<li>Survey on expert panels (24\/08\/2018)<\/li>\n<li><a href=\"http:\/\/www.encepp.eu\/code_of_conduct\/\" target=\"_blank\" rel=\"noopener noreferrer\">The ENCePP Code of Conduct - For Scientific Independence and Transparency in the Conduct of Pharmacoepidemiological and Pharmacovigilance Studies (2018)<\/a><\/li>\n<li><a href=\"https:\/\/ec.europa.eu\/health\/human-use\/paediatric-medicines\/developments\/2016_pc_report_2017_en\" target=\"_blank\" rel=\"noopener noreferrer\">Paediatric Regulation Consultation Questions and Responses MT 050217 (2017)<\/a><\/li>\n<li><a href=\"https:\/\/www.ema.europa.eu\/en\/ich-e11r1-step-5-guideline-clinical-investigation-medicinal-products-pediatric-population\" target=\"_blank\" rel=\"noopener noreferrer\">ICH E11 (R1) guideline on clinical investigation of medicinal products in the pediatric population (2016\/2017)<\/a><\/li>\n<li><a href=\"https:\/\/ec.europa.eu\/health\/medicinal-products-for-human-use\/public-consultation-on-summary-of-clinical-trial-results-for_it\" target=\"_blank\" rel=\"noopener noreferrer\">Summary of Clinical Trial Results for Laypersons (August 2016)<\/a><\/li>\n<li><a href=\"https:\/\/ec.europa.eu\/health\/sites\/health\/files\/files\/paediatrics\/docs\/paediatrics_10_years_ema_technical_report.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">EnprEMA data collection for the 10 year report to the European Commission on the public health effects of the Paediatric Regulation (November 2015)<\/a><\/li>\n<li>Contribution to the topic of transition from paediatrics to adults clinical care settings by providing documents on Thalassaemia and HIV infection patients (May 2015)<\/li>\n<li>EnprEMA request for information to develop a Global Paediatric Clinical Trials Network (October 2014)<\/li>\n<li>Stakeholder consultation for Horizon 2020 Societal Challenge \u201cHealth, demographic change and wellbeing\u201d for the programming exercise 2016\/2017 (September 2014)<\/li>\n<li><a href=\"https:\/\/www.ema.europa.eu\/en\/gaucher-disease-strategic-collaborative-approach-european-medicines-agency-food-drug-administration\" target=\"_blank\" rel=\"noopener noreferrer\">Gaucher disease. A strategic collaborative approach from EMA and FDA (EMA\/44410\/2014)<\/a><\/li>\n<li>Contribution to amendments proposed by GRiP (FP7- HEALTH \u2013 2010-261060) to the draft Regulation on Clinical Trials on medicinal products for human use (May 2013)<\/li>\n<li><a href=\"https:\/\/www.ema.europa.eu\/en\/extrapolation-efficacy-safety-medicine-development%20\" target=\"_blank\" rel=\"noopener noreferrer\">Concept paper on extrapolation of efficacy and safety in medicine development (EMA\/129698\/2012)<\/a><\/li>\n<li><a href=\"https:\/\/www.ema.europa.eu\/en\/involvement-children-young-people-paediatric-committee%20\" target=\"_blank\" rel=\"noopener noreferrer\">Concept paper on the involvement of children and young people at the Paediatric Committee (PDCO) (EMA\/PDCO\/388684\/2012)<\/a><\/li>\n<\/ul>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n<div class=\"et_pb_section_3 et_pb_section et_section_regular et_block_section\">\n<div class=\"et_pb_row_3 et_pb_row et_block_row\">\n<div class=\"et_pb_column_3 et_pb_column et_pb_column_4_4 et-last-child et_block_column et_pb_css_mix_blend_mode_passthrough\">\n<div class=\"et_pb_code_0 et_pb_code et_pb_module\"><div class=\"et_pb_code_inner\"><!--<a id=\"btn2\" style=\"display:none;\"><\/a><a id=\"btn4\" style=\"display:none;\"><\/a>-->\n<script>\n(function( $ ) {\n \n var totProgetti=30;\n for(let i = 1; i <= totProgetti; i++) {\n \n var myBtn = (\"#btn\" + i);\n\/\/$(document).on('click', '#btn1', function(event) {\n $(\"#btn\" + i).click( function(event){\n \/\/alert(\"you clicked \" + i);\n \n \/\/event.preventDefault();\n \/\/var href = $(this).attr(\"href\");\n \/\/console.log(href); \n \n readMoreClick(i);\n\n \/\/event.preventDefault();\n });\n}\n \n \/\/event.preventDefault();\n \n \n})( jQuery );\n\n\n \n \/\/ se vengo da un'ancora, apro il relativo leggi tutto\nfunction checkAnchor () {\n var addr = window.location.href ;\n \/\/console.log(\"---\"+addr); \n if (addr.indexOf (\"#\") != -1) {\n var cut = addr.slice(addr.indexOf (\"#\")+1);\n console.log(\"SI \"+cut); \n var readDiv = document.getElementById(\"readmore\"+cut);\n \/\/var readDiv = document.getElementById(\"readmore10\");\n readDiv.classList.add('readOpen');\n \/\/document.getElementById(\"btn\"+cut).innerHTML=\"Chiudi\";\n \n }\n}\nwindow.onload = checkAnchor; \n \n \nwindow.addEventListener ? \nwindow.addEventListener(\"load\",checkAnchor,false) : \nwindow.attachEvent && window.attachEvent(\"onload\",checkAnchor);\n<\/script><\/div><\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":4114,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-4123","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Etica e regolatorio - Fondazione Gianni Benzi - ETS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/benzifoundation.org\/it\/expertise\/etica-e-regolatorio\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Etica e regolatorio - Fondazione Gianni Benzi - ETS\" \/>\n<meta property=\"og:url\" content=\"https:\/\/benzifoundation.org\/it\/expertise\/etica-e-regolatorio\/\" \/>\n<meta property=\"og:site_name\" content=\"Fondazione Gianni Benzi - ETS\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-24T16:06:50+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/expertise\\\/etica-e-regolatorio\\\/\",\"url\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/expertise\\\/etica-e-regolatorio\\\/\",\"name\":\"Etica e regolatorio - Fondazione Gianni Benzi - ETS\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/#website\"},\"datePublished\":\"2026-01-21T22:40:38+00:00\",\"dateModified\":\"2026-03-24T16:06:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/expertise\\\/etica-e-regolatorio\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/benzifoundation.org\\\/it\\\/expertise\\\/etica-e-regolatorio\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/expertise\\\/etica-e-regolatorio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Expertise\",\"item\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/expertise\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Etica e regolatorio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/#website\",\"url\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/\",\"name\":\"Fondazione Gianni Benzi - ETS\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/benzifoundation.org\\\/it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Etica e regolatorio - Fondazione Gianni Benzi - ETS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/benzifoundation.org\/it\/expertise\/etica-e-regolatorio\/","og_locale":"it_IT","og_type":"article","og_title":"Etica e regolatorio - Fondazione Gianni Benzi - ETS","og_url":"https:\/\/benzifoundation.org\/it\/expertise\/etica-e-regolatorio\/","og_site_name":"Fondazione Gianni Benzi - ETS","article_modified_time":"2026-03-24T16:06:50+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/benzifoundation.org\/it\/expertise\/etica-e-regolatorio\/","url":"https:\/\/benzifoundation.org\/it\/expertise\/etica-e-regolatorio\/","name":"Etica e regolatorio - Fondazione Gianni Benzi - ETS","isPartOf":{"@id":"https:\/\/benzifoundation.org\/it\/#website"},"datePublished":"2026-01-21T22:40:38+00:00","dateModified":"2026-03-24T16:06:50+00:00","breadcrumb":{"@id":"https:\/\/benzifoundation.org\/it\/expertise\/etica-e-regolatorio\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/benzifoundation.org\/it\/expertise\/etica-e-regolatorio\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/benzifoundation.org\/it\/expertise\/etica-e-regolatorio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/benzifoundation.org\/it\/"},{"@type":"ListItem","position":2,"name":"Expertise","item":"https:\/\/benzifoundation.org\/it\/expertise\/"},{"@type":"ListItem","position":3,"name":"Etica e regolatorio"}]},{"@type":"WebSite","@id":"https:\/\/benzifoundation.org\/it\/#website","url":"https:\/\/benzifoundation.org\/it\/","name":"Fondazione Gianni Benzi - ETS","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/benzifoundation.org\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"}]}},"_links":{"self":[{"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/pages\/4123","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/comments?post=4123"}],"version-history":[{"count":5,"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/pages\/4123\/revisions"}],"predecessor-version":[{"id":4889,"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/pages\/4123\/revisions\/4889"}],"up":[{"embeddable":true,"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/pages\/4114"}],"wp:attachment":[{"href":"https:\/\/benzifoundation.org\/it\/wp-json\/wp\/v2\/media?parent=4123"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}